The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy Outcomes
Abstract
OBJECTIVE: To investigate the effect of intrauterine selective serotonin reuptake inhibitor (SSRI) exposure on pregnancy outcomes. DESIGN: Prospective cohort study. SETTING: Department of Obstetrics, Aarhus University Hospital, Aarhus, Denmark. PARTICIPANTS: Pregnant women receiving prenatal care in our hospital from 1989 to 2006. MAIN EXPOSURE: Maternal SSRI use during pregnancy. OUTCOME MEASURES: Gestational age, birth weight, head circumference, 5-minute Apgar score, and admission to the neonatal intensive care unit. RESULTS: Three hundred twenty-nine pregnant women reported treatment with SSRIs, 4902 were not treated with SSRIs but had a history of psychiatric illness, and 51 770 reported no history of psychiatric illness. Gestational age was 5 days (95% confidence interval [CI], -6 to -3) shorter and the odds ratio (OR) for preterm birth was 2.0 (95% CI, 1.3-3.2) in the women exposed to SSRIs compared with women with no history of psychiatric illness. In utero-exposed newborns had increased risk of admission to the neonatal intensive care unit (OR, 2.4; 95% CI, 1.7-3.4) and of 5-minute Apgar scores of less than 8 (OR, 4.4; 95% CI, 2.6-7.6) compared with those not exposed. Head circumference and birth weight did not differ between infants in the exposed and unexposed groups. The results were similar when compared with infants of women with a psychiatric history. CONCLUSIONS: Exposure to SSRIs during pregnancy was associated with an increased risk of preterm delivery, a low 5-minute Apgar score, and neonatal intensive care unit admission, which was not explained by lower Apgar scores or gestational age. The study justifies increased awareness to the possible effects of intrauterine exposure to antidepressants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among AD, SSRIs and, possibly, serotonin and noradrenaline reuptake inhibitors (SNRIs) have been associated with preterm labor, respiratory distress, serotonin rebound syndrome, pulmonary hypertension and feeding problems in the neonate (557-559).”
From Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) · cites this paper as [557]
Citations
Cites
Compendium of physical activities: an update of activity codes and MET intensities
AINSWORTH, B. E., HASKELL, W. L., WHITT, M. C., IRWIN, M. L., SWARTZ, A. M., STRATH, S. J., O???BRIEN, W. L., BASSETT, D. R., SCHMITZ, K. H., EMPLAINCOURT, P. O., et al. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200009001-00009 · Cited by 8,497
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733
Esposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G., D'Armiento, M., D'Andrea, F., & Giugliano, D. (2004) · JAMA · doi:10.1001/jama.292.12.1440 · Cited by 2,126
Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging
Seeman, T. E., McEwen, B. S., Rowe, J. W., & Singer, B. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081072698 · Cited by 1,385
Olds, D. L. (1997) · JAMA · doi:10.1001/jama.1997.03550080047038 · Cited by 1,372
Cohort study of depressed mood during pregnancy and after childbirth
Evans, J., Heron, J., Francomb, H., Oke, S., & Golding, J. (2001) · BMJ · doi:10.1136/bmj.323.7307.257 · Cited by 1,273
Socioeconomic Inequalities in Health
Adler, N. E. (1993) · JAMA · doi:10.1001/jama.1993.03500240084031 · Cited by 1,147
CORONARY DISEASE AMONG UNITED STATES SOLDIERS KILLED IN ACTION IN KOREA
Enos, W. F. (1953) · JAMA · doi:10.1001/jama.1953.03690120006002 · Cited by 891
Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Chambers, C., Hernández–Dı́az, S., Marter, L. J. V., Werler, M. M., Louik, C., Jones, K. L., & Mitchell, A. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052744 · Cited by 877
Family Poverty, Welfare Reform, and Child Development
Duncan, G. J., & Brooks‐Gunn, J. (2000) · Child Development · doi:10.1111/1467-8624.00133 · Cited by 850
Cited by
Sorted by citations
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Rai, D., Lee, B. K., Dalman, C., Golding, J., Lewis, G., & Magnusson, C. (2013) · BMJ · doi:10.1136/bmj.f2059 · Cited by 365
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Reis, M., & Källén, B. A. J. (2010) · Psychological Medicine · doi:10.1017/s0033291709992194 · Cited by 339
Pregnant women with posttraumatic stress disorder and risk of preterm birth
Yonkers, K. A., Smith, M. V., Forray, A., Epperson, C. N., Costello, D., Lin, H., & Belanger, K. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.558 · Cited by 331
Ross, L. E., Grigoriadis, S., Mamisashvili, L., VonderPorten, E. H., Roerecke, M., Rehm, J., Dennis, C.-L., Koren, G., Steiner, M., Mousmanis, P., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.684 · Cited by 268
Depression in pregnancy, infant birth weight and DNA methylation of imprint regulatory elements
Liu, Y., Murphy, S. K., Murtha, A. P., Fuemmeler, B. F., Schildkraut, J. M., Huang, Z., Overcash, F. M., Kurtzberg, J., Jirtle, R. L., Iversen, E. S., et al. (2012) · Epigenetics · doi:10.4161/epi.20734 · Cited by 191
Huang, H., Coleman, S., Bridge, J. A., Yonkers, K., & Katon, W. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.08.002 · Cited by 180
Marroun, H. E., Jaddoe, V. W. V., Hudziak, J. J., Roza, S. J., Steegers, E. A. P., Albert Hofman, D., Verhulst, F. C., White, T. J. H., Stricker, B. H. C., & Tiemeier, H. W. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2333 · Cited by 178
Antidepressant use in pregnancy: a critical review focused on risks and controversies
Byatt, N., Deligiannidis, K. M., & Freeman, M. P. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12042 · Cited by 158
Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies
Hayes, R. M., Wu, P., Shelton, R. C., Cooper, W. O., Dupont, W. D., Mitchel, E., & Hartert, T. V. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.04.028 · Cited by 149
Eke, A. C., Saccone, G., & Berghella, V. (2016) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14144 · Cited by 143
Pregnancy Outcome After Exposure to Antidepressants and the Role of Maternal Depression
Nordeng, H., van Gelder, M. M. H. J., Spigset, O., Koren, G., Einarson, A., & Eberhard‐Gran, M. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3182490eaf · Cited by 133
Malm, H. T., Sourander, A., Gissler, M., Gyllenberg, D., Hinkka‐Yli‐Salomäki, S., McKeague, I. W., Artama, M., & Brown, A. S. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14121575 · Cited by 132
Use of psychotropic drugs during pregnancy and breast‐feeding
Larsen, E. R., Damkier, P., Pedersen, L. H., Fenger‐Grøn, J., Mikkelsen, R. L., Nielsen, R. E., Linde, V., Knudsen, H. E. D., Skaarup, L., & Videbech, P. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12479 · Cited by 128
Self-citationPrenatal exposure to antidepressant medications and neurodevelopmental outcomes: A systematic review
Gentile, S., & Galbally, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.02.125 · Cited by 123
Huybrechts, K. F., Sanghani, R. S., Avorn, J., & Urato, A. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092778 · Cited by 128
Antidepressant Use in Pregnant and Postpartum Women
Yonkers, K. A., Blackwell, K. A., Glover, J. G., & Forray, A. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153626 · Cited by 121
Morales, D. R., Slattery, J., Evans, S., & Kurz, X. (2018) · BMC Medicine · doi:10.1186/s12916-017-0993-3 · Cited by 118
Marroun, H. E., White, T. J. H., van der Knaap, N. J. F., Homberg, J. R., Fernández, G., Schoemaker, N. K., Jaddoe, V. W. V., Hofman, A., Verhulst, F. C., Hudziak, J. J., et al. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.127746 · Cited by 117
In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder
Gidaya, N. B., Lee, B. K., Burstyn, I., Yudell, M., Mortensen, E. L., & Newschaffer, C. J. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2128-4 · Cited by 115
Olivier, J. D. A., Åkerud, H., Kaihola, H., Pawluski, J. L., Skalkidou, A., Högberg, U., & Poromaa, I. S. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00073 · Cited by 112
Casper, R. C., Gilles, A. A., Fleisher, B. E., Baran, J., Enns, G. M., & Lazzeroni, L. C. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2270-z · Cited by 111
Glover, M. E., & Clinton, S. M. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.04.008 · Cited by 109
Placental serotonin: implications for the developmental effects of SSRIs and maternal depression
Velasquez, J. C., Goeden, N., & Bonnin, A. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00047 · Cited by 106
El Marroun, H., White, T., Verhulst, F. C., & Tiemeier, H. (2014) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-014-0558-3 · Cited by 92
Depression and Serotonin Reuptake Inhibitor Treatment as Risk Factors for Preterm Birth
Yonkers, K. A., Norwitz, E. R., Smith, M. V., Lockwood, C. J., Gotman, N., Luchansky, E., Lin, H., & Belanger, K. D. (2012) · Epidemiology · doi:10.1097/ede.0b013e31825838e9 · Cited by 82
Fumeaux, C. J. F., Harari, M. M., Weisskopf, E., Eap, C. B., Epiney, M., Vial, Y., Csajka, C., Graz, M. B., & Panchaud, A. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1658740 · Cited by 82
Neonatal Morbidity After Maternal Use of Antidepressant Drugs During Pregnancy
Nörby, U., Forsberg, L., Wide, K., Sjörs, G., Winbladh, B., & Källén, K. (2016) · PEDIATRICS · doi:10.1542/peds.2016-0181 · Cited by 80
Klinger, G., Frankenthal, D., Merlob, P., Diamond, G. W., Sirota, L., Levinson-Castiel, R., Linder, N., Stahl, B., & Inbar, D. (2011) · Journal of Perinatology · doi:10.1038/jp.2010.211 · Cited by 77
Psychotropics in pregnancy: Safety and other considerations
Oyebode, F., Rastogi, A., Berrisford, G. S., & Coccia, F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.03.008 · Cited by 77
Ellfolk, M. A., & Malm, H. T. (2010) · Reproductive Toxicology · doi:10.1016/j.reprotox.2010.04.015 · Cited by 74
Mitchell, J., & Goodman, J. H. (2018) · Archives of Women s Mental Health · doi:10.1007/s00737-018-0844-z · Cited by 61
Drug treatment for mood disorders in pregnancy
Gentile, S. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283413451 · Cited by 60
Halmøy, A., Johansson, S., Winge, I., McKinney, J. A., Knappskog, P. M., & Haavik, J. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.124 · Cited by 59
Pregnancy Outcomes Following Use of Escitalopram: A Prospective Comparative Cohort Study
Klieger, C., Weitzner, B., Panchaud, A., Pistelli, A., Einarson, T. R., Koren, G., & Einarson, A. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011405524 · Cited by 55
Ornoy, A., & Koren, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102370 · Cited by 54
Gentile, S. (2010) · CNS Spectrums · doi:10.1017/s1092852900027449 · Cited by 53
Zhao, X., Liu, Q., Cao, S., Pang, J., Zhang, H., Feng, T., Deng, Y., Yao, J., & Li, H. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.061 · Cited by 53
Weisskopf, E., Fumeaux, C. J. F., Graz, M. B., Harari, M. M., Tolsa, J., Claris, O., Vial, Y., Eap, C. B., Csajka, C., & Panchaud, A. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.997708 · Cited by 52
Neonatal Outcomes After Late-Gestation Exposure to Selective Serotonin Reuptake Inhibitors
Grzeskowiak, L. E., Gilbert, A. L., & Morrison, J. L. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31826686bc · Cited by 49
MOTHERISK ROUNDS: The Fetal Safety of Fluoxetine: A Systematic Review and Meta-Analysis
Riggin, L., Frankel, Z., Moretti, M. E., Pupco, A., & Koren, G. (2013) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30965-8 · Cited by 46
Viktorin, A., Uher, R., Kolevzon, A., Reichenberg, A., Levine, S. Z., & Sandin, S. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.1727 · Cited by 45
The use of antidepressant medication in pregnancy
Ray, S. L., & Stowe, Z. N. (2013) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2013.09.005 · Cited by 47
Mediators of Adverse Birth Outcomes Among Socially Disadvantaged Women
Gavin, A. R., Nurius, P. S., & Logan‐Greene, P. (2011) · Journal of Women s Health · doi:10.1089/jwh.2011.2766 · Cited by 48
Roca, A., Garcia-Esteve, L., Imaz, M. L., Torres, A., Hernández, S., Botet, F., Gelabert, E., Subirà, S., Plaza, A., Valdés, M., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.07.022 · Cited by 45
Maternal depression, antidepressant use in pregnancy and Apgar scores in infants
Jensen, H. M., Gr⊘n, R., Lidegaard, Ø., Pedersen, L. H., Andersen, P. K., & Kessing, L. V. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.115931 · Cited by 42
Self-citationSelective serotonin reuptake inhibitors in human pregnancy: On the way to resolving the controversy
Ornoy, A., & Koren, G. (2013) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2013.11.007 · Cited by 41
Cantarutti, A., Merlino, L. G., Monzani, E., Giaquinto, C., & Corrao, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168115 · Cited by 41
Perinatal anxiety: approach to diagnosis and management in the obstetric setting
Thorsness, K. R., Watson, C., & LaRusso, E. M. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.05.017 · Cited by 45
Acculturation, depressive symptoms, estriol, progesterone, and preterm birth in Hispanic women
Ruiz, R. J., Marti, C. N., Pickler, R., Murphey, C., Wommack, J., & Brown, C. E. L. (2012) · Archives of Women's Mental Health · doi:10.1007/s00737-012-0258-2 · Cited by 40
Gawley, L., Einarson, A., & Bowen, A. (2011) · Advances in Health Sciences Education · doi:10.1007/s10459-011-9289-0 · Cited by 38
Viktorin, A., Lichtenstein, P., Lundholm, C., Almqvist, C., D'Onofrio, B. M., Larsson, H., Landén, M., & Magnusson, P. K. E. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyv351 · Cited by 38
Prenatal Antidepressant Exposure: Clinical and Preclinical Findings
Bourke, C. H., Stowe, Z. N., & Owens, M. J. (2014) · Pharmacological Reviews · doi:10.1124/pr.111.005207 · Cited by 39
Chang, Q., Ma, X., Xu, X., Su, H., Wu, Q., & Zhao, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00659 · Cited by 37
A review of the use of psychotropic medication in pregnancy
Galbally, M., Snellen, M., & Lewis, A. J. (2011) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32834b92f3 · Cited by 35
Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
Diav‐Citrin, O., & Ornoy, A. (2011) · Obstetrics and Gynecology International · doi:10.1155/2012/698947 · Cited by 34
Ornoy, A., & Koren, G. (2017) · Birth Defects Research · doi:10.1002/bdr2.1078 · Cited by 32
Grzeskowiak, L. E., Gilbert, A. L., & Morrison, J. L. (2011) · Drug Safety · doi:10.2165/11593130-000000000-00000 · Cited by 31
Selective serotonin reuptake inhibitors for depression in pregnancy
Susser, L. C., Sansone, S. A., & Hermann, A. D. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.07.011 · Cited by 35
Podrebarac, S. K., Duerden, E. G., Chau, V., GRUNAU, R. E., Synnes, A. R., Oberlander, T. F., & Miller, S. P. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.11.025 · Cited by 31
Jensen, H. M., Grøn, R., Lidegaard, Ø., Pedersen, L. H., Andersen, P. K., & Kessing, L. V. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3029-5 · Cited by 29
Self-citationXing, D., Wu, R., Chen, L., & Wang, T. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110231 · Cited by 29
Bilszta, J. L. C., Tsuchiya, S., Han, K., Buist, A., & Einarson, A. (2010) · Archives of Women s Mental Health · doi:10.1007/s00737-010-0197-8 · Cited by 27
Engelstad, H. J., Roghair, R. D., Calarge, C. A., Colaizy, T. T., Stuart, S. P., & Haskell, S. E. (2013) · Neonatology · doi:10.1159/000356774 · Cited by 27
Developmental Exposure to Fluoxetine Modulates the Serotonin System in Hypothalamus
Berg, C., Bäckström, T., Winberg, S., Lindberg, R. H., & Brandt, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055053 · Cited by 26
Prenatal Exposure to Selective Serotonin Reuptake Inhibitors and Infant Outcome
Malm, H. T. (2012) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31826d07ea · Cited by 25
Selective serotonin reuptake inhibitors in pregnancy and infant outcomes
Jefferies, A. L. (2011) · Paediatrics & Child Health · doi:10.1093/pch/16.9.562 · Cited by 23
Latendresse, G., & Ruiz, R. J. (2011) · Journal of Midwifery & Women s Health · doi:10.1111/j.1542-2011.2010.00023.x · Cited by 23
Yang, F., Chen, J., Miao, M., Yuan, W., Li, L., Liang, H., Ehrenstein, V., & Li, J. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016368 · Cited by 22
Hypericum perforatum use during pregnancy and pregnancy outcome
Kolding, L., Pedersen, L. H., Henriksen, T. B., Olsen, J., & Grzeskowiak, L. E. (2015) · Reproductive Toxicology · doi:10.1016/j.reprotox.2015.10.003 · Cited by 21
Self-citationPharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approach
Uğuz, F. (2015) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2015-1673 · Cited by 20
Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density
Dubnov‐Raz, G., Hemilä, H., Vurembrand, Y., Kuint, J., & Maayan‐Metzger, A. (2011) · Early Human Development · doi:10.1016/j.earlhumdev.2011.08.005 · Cited by 20
Prenatal exposure to antidepressants and risk of epilepsy in childhood
Mao, Y., Pedersen, L. H., Christensen, J., Vestergaard, M., Zhou, W., Olsen, J., & Sun, Y. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4072 · Cited by 19
Self-citationThe Use of Antidepressants in Pregnancy: Focus on Maternal Risks
Gadot, Y., & Koren, G. (2015) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30364-9 · Cited by 19
Antidepressant Medication Use in Pregnancy
Hackley, B. K. (2010) · Journal of Midwifery & Women s Health · doi:10.1016/j.jmwh.2009.11.003 · Cited by 19
Eleftheriou, G., Zandonella Callegher, R., Butera, R., De Santis, M., Cavaliere, A. F., Vecchio, S., Pistelli, A., Mangili, G., Bondi, E., Somaini, L., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20166565 · Cited by 17
Neonatal outcomes in pregnant women with untreated and treated panic disorder
Uğuz, F., Yüksel, G., Onur, Ö. Ş., Karşıdağ, Ç., Gezginç, K., & Arpacı, N. (2018) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2018.10.001 · Cited by 17
Aagaard, L., & Hansen, E. H. (2010) · BMC Research Notes · doi:10.1186/1756-0500-3-176 · Cited by 17
Further Findings Linking SSRIs During Pregnancy and Persistent Pulmonary Hypertension of the Newborn
Galbally, M., Gentile, S., & Lewis, A. J. (2012) · CNS Drugs · doi:10.2165/11630310-000000000-00000 · Cited by 16
Henriksen, K. N., Spigset, O., Brandlistuen, R. E., Ystrøm, E., Koren, G., & Nordeng, H. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw049 · Cited by 16
Hogue, A. N., Temple, M. E., Lagzdins, M., Worley, S., Scwersenski, J., Floyd, R., & Saker, F. (2017) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-16133 · Cited by 16
Ornoy, A., & Koren, G. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1430139 · Cited by 15
Leibovitch, L., Rymer‐Haskel, N., Schushan‐Eisen, I., Kuint, J., Strauss, T., & Maayan‐Metzger, A. (2013) · Neonatology · doi:10.1159/000350506 · Cited by 15
Kivistö, J., Lehto, S. M., Halonen, K., Georgiadis, L., & Heinonen, S. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154628 · Cited by 12
Aronson, J. K. (2014) · Side effects of drugs annual · doi:10.1016/b978-0-444-62635-6.09983-6 · Cited by 12
Perinatal depression: detection and treatment
Muzik, M., Thelen, K., & Rosenblum, K. L. (2011) · Neuropsychiatry · doi:10.2217/npy.10.8 · Cited by 11
Altered activities of CYP1A1 and CYP19A1 enzymes in women using SSRI medication during pregnancy
Sahlman, H., Itkonen, A., Lehtonen, M., Keski‐Nisula, L., & Rysä, J. (2022) · Placenta · doi:10.1016/j.placenta.2022.09.013 · Cited by 10
McLean, K. A., Murphy, K. E., Dalfen, A., & Shea, A. K. (2019) · Archives of Women s Mental Health · doi:10.1007/s00737-019-00954-8 · Cited by 10
Kapra, O., Rotem, R. S., & Gross, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.555740 · Cited by 10
Exposure to selective serotonin reuptake inhibitors in utero and early elementary school outcomes
Kragholm, K. H., Andersen, M. P., Mortensen, R. N., Bech, L. F., Polcwiartek, C., Rohde, C., Torp-Pedersen, C. T., Videbech, P., & Nielsen, J. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12867 · Cited by 10
Gebelikte Psikotrop İlaç Kullanımı: Bir Güncelleme
Çetin, M. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20110706032759 · Cited by 8
Effects of maternal psychotropic drug dosage on birth outcomes
Michielsen, L. A., Kuijpers, H. J. H., van der Heijden, F., & Janssen, P. K. C. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s53430 · Cited by 8
Fenger‐Grøn, J., Thomsen, M., Andersen, K. S., & Nielsen, R. G. (2011) · PubMed · Cited by 8
The Role of the Neonatal Nurse Practitioner in the Community Hospital Level I Nursery
Hatch, J. (2012) · Neonatal Network The Journal of Neonatal Nursing · doi:10.1891/0730-0832.31.3.141 · Cited by 8
Liu, T., Zeng, N., Xu, Y., Fan, T., Wang, F., Liu, C., Zhao, Y., Ni, S., Mei, H., Wu, S., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03263-y · Cited by 7
Sutter‐Dallay, A. (2010) · L information psychiatrique · doi:10.1684/ipe.2010.0592 · Cited by 7
Bromley, R., Wieck, A., MAKAROVA, D., Tower, C. L., WOOD, A. G., & Clayton‐Smith, J. (2012) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539512000095 · Cited by 6
Management of Substance Abuse in Pregnancy: Maternal and Neonatal Aspects
Brandt, L., Leifheit, A. K., Finnegan, L. P., & Fischer, G. (2014) · Springer eBooks · doi:10.1007/978-3-642-54562-7_12 · Cited by 6
Drugs during Pregnancy and Lactation: New Solutions to Serious Challenges
Koren, G., Clark, S. M., & Matsui, D. M. (2012) · Obstetrics and Gynecology International · doi:10.1155/2012/206179 · Cited by 6
Metadata
- Authors
- Lund, N., Pedersen, L. H., & Henriksen, T. B.
- Affiliations
- Bandim Health Project (GW)
- Venue
- Archives of Pediatrics & Adolescent Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2009-10-05
- Volume
- 163
- Issue
- 10
- Pages
- 949
- ISSN
- 1072-4710 (ISSN-L)
- OpenAlex
- W2048933622
- Cited by
- 153
- References
- 52
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 6 · 2022: 2 · 2020: 3 · 2019: 3 · 2018: 9 · 2017: 5 · 2016: 12 · 2015: 14 · 2014: 10 · 2013: 20 · 2012: 20
- FWCI
- 22.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Pediatrics and Adolescent Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sundhed og Sygdom, Det Frie Forskningsråd
- Medical Research Council
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- selective serotonin reuptake inhibitors, prenatal antidepressant exposure, pregnancy outcomes, preterm birth, Apgar score, neonatal intensive care admission, birth weight, head circumference, gestational age, prenatal exposure
- MeSH terms
- Antidepressive Agents, Denmark, Depressive Disorder, Female, Humans, Infant, Newborn, Pregnancy, Pregnancy Outcome, Prenatal Exposure Delayed Effects, Prospective Studies, Multivariate Analysis, Linear Models, Logistic Models, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review